APA (7th ed.) Citation

Tamura, Y. O., Sugama, J., Abe, S., Shimizu, Y., Hirose, H., & Watanabe, M. (2023). Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity. Pharmacology Research & Perspectives, 11(1), 1. https://doi.org/10.1002/prp2.1043

Chicago Style (17th ed.) Citation

Tamura, Yumiko Okano, Jun Sugama, Shin-ichi Abe, Yuji Shimizu, Hideki Hirose, and Masanori Watanabe. "Selective Somatostatin Receptor 5 Inhibition Improves Hepatic Insulin Sensitivity." Pharmacology Research & Perspectives 11, no. 1 (2023): 1. https://doi.org/10.1002/prp2.1043.

MLA (9th ed.) Citation

Tamura, Yumiko Okano, et al. "Selective Somatostatin Receptor 5 Inhibition Improves Hepatic Insulin Sensitivity." Pharmacology Research & Perspectives, vol. 11, no. 1, 2023, p. 1, https://doi.org/10.1002/prp2.1043.